• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[HYDRA meta-analysis: hypofractionated radiotherapy for prostate cancer-have we reached our goal?].

作者信息

Shelan Mohamed

机构信息

Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Schweiz.

出版信息

Strahlenther Onkol. 2025 Jun 24. doi: 10.1007/s00066-025-02427-7.

DOI:10.1007/s00066-025-02427-7
PMID:40553142
Abstract
摘要

相似文献

1
[HYDRA meta-analysis: hypofractionated radiotherapy for prostate cancer-have we reached our goal?].[HYDRA荟萃分析：前列腺癌的大分割放疗——我们实现目标了吗？]
Strahlenther Onkol. 2025 Jun 24. doi: 10.1007/s00066-025-02427-7.
2
Rectal/urinary toxicity after hypofractionated vs. conventional radiotherapy in high risk prostate cancer: systematic review and meta analysis.高危前列腺癌患者接受低分割与常规分割放疗后的直肠/泌尿毒性：系统评价和荟萃分析。
Eur Rev Med Pharmacol Sci. 2017 Aug;21(16):3563-3575.
3
Radiotherapy for diffuse brainstem glioma in children and young adults.儿童和青年弥漫性脑干胶质瘤的放射治疗
Cochrane Database Syst Rev. 2016 Jun 27;2016(6):CD010439. doi: 10.1002/14651858.CD010439.pub2.
4
Rectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: systematic review and meta analysis.低/中危局限性前列腺癌患者接受大分割放疗与传统放疗后的直肠/泌尿毒性：系统评价与荟萃分析
Oncotarget. 2017 Mar 7;8(10):17383-17395. doi: 10.18632/oncotarget.14798.
5
Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature.中度亚分割与常规分割前列腺放射治疗后的毒性：当前文献的系统评价和荟萃分析。
Crit Rev Oncol Hematol. 2021 Sep;165:103432. doi: 10.1016/j.critrevonc.2021.103432. Epub 2021 Aug 3.
6
External beam radiation dose escalation for high grade glioma.高级别胶质瘤的外照射放疗剂量递增
Cochrane Database Syst Rev. 2016 Aug 19(8):CD011475. doi: 10.1002/14651858.CD011475.pub2.
7
Evaluating organs-at-risk constraints in hypofractionated locoregional breast cancer radiotherapy with integrated boost.在采用同步推量的大分割局部区域乳腺癌放疗中评估危及器官的限制条件。
Br J Radiol. 2025 Sep 1;98(1173):1493-1497. doi: 10.1093/bjr/tqaf155.
8
Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis.手术与放疗治疗局限性前列腺癌的比较：系统评价和荟萃分析。
Eur Urol. 2016 Jul;70(1):21-30. doi: 10.1016/j.eururo.2015.11.010. Epub 2015 Dec 15.
9
Post-operative hypofractionated radiotherapy for prostate cancer: a mono-institutional analysis of toxicity and clinical outcomes.前列腺癌术后短程放疗：单机构毒性和临床结局分析。
J Cancer Res Clin Oncol. 2022 Jan;148(1):89-95. doi: 10.1007/s00432-021-03816-y. Epub 2021 Sep 30.
10
Understanding Barriers to Engagement With a Prostate Cancer Research and Genetic Risk Service Among UK Men of Black African or Black Caribbean Ancestry.了解英国非洲裔或加勒比裔黑人男性参与前列腺癌研究和遗传风险服务的障碍。
Health Expect. 2025 Jun;28(3):e70282. doi: 10.1111/hex.70282.

本文引用的文献

1
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.立体定向体部放射治疗局限性前列腺癌的 3 期临床试验。
N Engl J Med. 2024 Oct 17;391(15):1413-1425. doi: 10.1056/NEJMoa2403365.
2
Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries : A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO).中低分割放射治疗作为局限性前列腺癌的确定性治疗：德语国家的实践模式：德国放射肿瘤学会前列腺癌专家小组（DEGRO）和德国癌症学会放射肿瘤学工作组（DKG-ARO）的调查。
Strahlenther Onkol. 2021 Nov;197(11):993-1000. doi: 10.1007/s00066-021-01820-2. Epub 2021 Aug 31.
3
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.超分割与常规分割放疗治疗前列腺癌的比较：HYPO-RT-PC 随机、非劣效、III 期临床试验的 5 年结果。
Lancet. 2019 Aug 3;394(10196):385-395. doi: 10.1016/S0140-6736(19)31131-6. Epub 2019 Jun 18.
4
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline.局限性前列腺癌的分割放疗：ASTRO、ASCO 和 AUA 循证指南的执行摘要。
Pract Radiat Oncol. 2018 Nov-Dec;8(6):354-360. doi: 10.1016/j.prro.2018.08.002. Epub 2018 Oct 11.
5
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.随机分组试验：一种低分割辐射方案治疗局限性前列腺癌。
J Clin Oncol. 2017 Jun 10;35(17):1884-1890. doi: 10.1200/JCO.2016.71.7397. Epub 2017 Mar 15.
6
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial.局部前列腺癌患者的低分割与常规分割放疗（HYPRO）：一项随机、多中心、开放标签、3 期临床试验的最终疗效结果。
Lancet Oncol. 2016 Aug;17(8):1061-1069. doi: 10.1016/S1470-2045(16)30070-5. Epub 2016 Jun 20.
7
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.常规分割与大分割高剂量调强放疗治疗前列腺癌：随机、非劣效性3期CHHiP试验的5年结果
Lancet Oncol. 2016 Aug;17(8):1047-1060. doi: 10.1016/S1470-2045(16)30102-4. Epub 2016 Jun 20.
8
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.比较低危前列腺癌患者两种放疗分割方案的随机 III 期非劣效性研究。
J Clin Oncol. 2016 Jul 10;34(20):2325-32. doi: 10.1200/JCO.2016.67.0448. Epub 2016 Apr 4.